COVID-19(15) Treatment(9) SARS-CoV-2(7) patients with COVID-19(6) implication(6) Tocilizumab(6) Patient(6) Pneumonia(5) pandemic(4) cytokine(4) immunomodulatory(4) Follow-up(4) Clinical deterioration(4) cytokine release(4) benefit(4) COVID-19 pneumonia(4) interleukin-6(4) male(4) pathophysiology(4) immunomodulatory therapy(4) rationale(4) treated(4) Area(4) with COVID-19(4) Cytokine release syndrome(4) systemic inflammation(4) in some(4) concomitant treatments(4) investigated(4) repurposed therapy(4)